|
ABOUT COMPANY
Voyager Therapeutics, Inc., a clinical-stage gene therapy company, is focused on developing treatments for patients with severe neurological diseases. The company is headquartered in Cambridge, Massachusetts.
|
EARNINGS
Gross Profit (TTM): 62375000
Market Capitalization: 102865000
Operating Margin (TTM): -6.36
PE Ratio: None
PEG Ratio: 0
Profit Margin: 0
Revenue Per Share (TTM): 0.423
Revenue (TTM): 15879000
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: -0.987
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -2.473
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: 11132000
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|